Enovis (ENOV) EPS (Diluted) Growth (3y) (2013 - 2026)
Powered by 
Analysis
Enovis (ENOV) EPS (Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | -12.16% |
| 2 | Intuitive Surgical | 126.82 Bn | 121.60 Bn | 1.96 Bn | 24.56% |
| 3 | Medtronic | 117.93 Bn | 109.11 Bn | 6.34 Bn | 24.50% |
| 4 | Stryker | 104.83 Bn | 101.36 Bn | 4.50 Bn | 19.81% |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | 50.83% |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn | -6.12% |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.14 Bn | 30.20 Bn | 830.00 Mn | 33.46% |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | 18.07% |
| 10 | Enovis | 1.07 Bn | 1.06 Bn | 359.25 Mn | 53.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 53.60% |
| Apr 3, 2026 | 29.81% |
| Dec 31, 2025 | -133.82% |
| Oct 3, 2025 | -101.10% |
| Jul 4, 2025 | -34.87% |
| Apr 4, 2025 | -76.96% |
| Dec 31, 2024 | -949.83% |
| Sep 27, 2024 | -46.86% |
| Jun 28, 2024 | -37.72% |
| Mar 29, 2024 | -73.85% |
| Dec 31, 2023 | 26.52% |
| Sep 29, 2023 | -29.64% |
| Jun 30, 2023 | 1.06% |
| Mar 31, 2023 | -86.49% |
| Dec 31, 2022 | -28.46% |
| Sep 30, 2022 | -94.48% |
| Jul 1, 2022 | 28.81% |
| Apr 1, 2022 | 30.79% |
| Dec 31, 2021 | -26.18% |
| Oct 1, 2021 | -18.57% |